# Registry of Pre-mixed Solutions in Critically Ill Patients on the Continuous Renal Replacement Therapy

> **NCT06983509** · — · COMPLETED · sponsor: **Vantive Health LLC** · enrollment: 228 (actual)

## Conditions studied

- Renal Insufficiency

## Interventions

- **DRUG:** Regiocit
- **DRUG:** Biphozyl
- **DRUG:** Prismasol 2

## Key facts

- **NCT ID:** NCT06983509
- **Lead sponsor:** Vantive Health LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-23
- **Primary completion:** 2025-09-11
- **Final completion:** 2025-09-11
- **Target enrollment:** 228 (ACTUAL)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06983509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06983509, "Registry of Pre-mixed Solutions in Critically Ill Patients on the Continuous Renal Replacement Therapy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06983509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*